This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
H Asada , Y Fukuda , S Tsunoda , M Yamaguchi , M Tonoike (1999). Frontal midline theta rhythms reflect alternative activation of prefrontal cortex and anterior cingulate cortex in humans. Neuroscience Letters 274, 29–32.
M Bares , M Brunovsky , M Kopecek , T Novak , P Stopkova , J Kozeny , P Sos , V Krajca , C Hoschl (2008). Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder. European Psychiatry 23, 350–355.
M Bares , M Brunovsky , M Kopecek , P Stopkova , T Novak , J Kozeny , C Hoschl (2007). Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study. Journal of Psychiatric Research 41, 319–325.
RM Berman , A Cappiello , A Anand , DA Oren , GR Heninger , DS Charney , JH Krystal (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry 47, 351–354.
V Bubenikova-Valesova , J Horacek , M Vrajova , C Hoschl (2008). Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neuroscience and Biobehavioral Reviews 32, 1014–1023.
IA Cook , AF Leuchter , ML Morgan , W Stubbeman , B Siegman , M Abrams (2005). Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. Journal of Psychiatric Research 39, 461–466.
IA Cook , AF Leuchter , M Morgan , E Witte , WF Stubbeman , M Abrams , S Rosenberg , SH Uijtdehaage (2002). Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology 27, 120–131.
IA Cook , AF Leuchter , SH Uijtdehaage , S Osato , DH Holschneider , M Abrams , S Rosenberg-Thompson (1998). Altered cerebral energy utilization in late life depression. Journal of Affective Disorders 49, 89–99.
IA Cook , AF Leuchter , E Witte , M Abrams , SH Uijtdehaage , W Stubbeman , S Rosenberg-Thompson , C Anderson-Hanley , JJ Dunkin (1999). Neurophysiologic predictors of treatment response to fluoxetine in major depression. Psychiatry Research 85, 263–273.
JF Deakin , J Lees , S McKie , JE Hallak , SR Williams , SM Dursun (2008). Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. Archives of General Psychiatry 65, 154–164.
B Ebert , S Mikkelsen , C Thorkildsen , FM Borgbjerg (1997). Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord. European Journal of Pharmacology 333, 99–104.
LA Hetem , JM Danion , P Diemunsch , C Brandt (2000). Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers. Psychopharmacology (Berlin) 152, 283–288.
AM Hunter , IA Cook , AF Leuchter (2007). The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder. Psychiatric Clinics of North America 30, 105–124.
R Ishii , K Shinosaki , S Ukai , T Inouye , T Ishihara , T Yoshimine , N Hirabuki , H Asada , T Kihara , SE Robinson , M Takeda (1999). Medial prefrontal cortex generates frontal midline theta rhythm. Neuroreport 10, 675–679.
SH Kennedy , JZ Konarski , ZV Segal , MA Lau , PJ Bieling , RS McIntyre , HS Mayberg (2007). Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. American Journal of Psychiatry 164, 778–788.
V Knott , C Mahoney , S Kennedy , K Evans (2000). Pre-treatment EEG and its relationship to depression severity and paroxetine treatment outcome. Pharmacopsychiatry 33, 201–205.
JH Krystal , G Sanacora , H Blumberg , A Anand , DS Charney , G Marek , CN Epperson , A Goddard , GF Mason (2002). Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Molecular Psychiatry 7 (Suppl. 1), S71–S80.
AF Leuchter , IA Cook , DJ DeBrota , AM Hunter , WZ Potter , CC McGrouther , ML Morgan , M Abrams , B Siegman (2008) Changes in brain function during administration of venlafaxine or placebo to normal subjects. Clinical EEG and Neuroscience Journal 39, 175–181.
AF Leuchter , IA Cook , A Hunter , A Korb (2009) Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence. Clinical EEG and Neuroscience 40, 78–83.
AF Leuchter , IA Cook , RB Lufkin , J Dunkin , TF Newton , JL Cummings , JK Mackey , DO Walter (1994). Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography. NeuroImage 1, 208–219.
AF Leuchter , IA Cook , EA Witte , M Morgan , M Abrams (2002). Changes in brain function of depressed subjects during treatment with placebo. American Journal of Psychiatry 159, 122–129.
AF Leuchter , SH Uijtdehaage , IA Cook , R O'Hara , M Mandelkern (1999). Relationship between brain electrical activity and cortical perfusion in normal subjects. Psychiatry Research 90, 125–140.
S Maeng , CA Zarate Jr., J Du , RJ Schloesser , J McCammon , G Chen , HK Manji (2008). Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biological Psychiatry 63, 349–352.
SJ Mathew , K Keegan , L Smith (2005). Glutamate modulators as novel interventions for mood disorders. Revista Brasileira de Psiquiatria 27, 243–248.
HS Mayberg (2003). Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin 65, 193–207.
J Penders , A Verstraete (2006). Laboratory guidelines and standards in clinical and forensic toxicology. Accreditation and quality assurance. Accreditation and Quality Assurance 11, 284–290.
D Pizzagalli , RD Pascual-Marqui , JB Nitschke , TR Oakes , CL Larson , HC Abercrombie , SM Schaefer , JV Koger , RM Benca , RJ Davidson (2001). Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. American Journal of Psychiatry 158, 405–415.
LM Rowland , JR Bustillo , PG Mullins , RE Jung , R Lenroot , E Landgraf , R Barrow , R Yeo , J Lauriello , WM Brooks (2005). Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. American Journal of Psychiatry 162, 394–396.
G Salvadore , BR Cornwell , V Colon-Rosario , R Coppola , C Grillon , CA Zarate Jr., HK Manji (2009). Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biological Psychiatry 65, 289–295.
ST Szabo , R Hado-Vieira , P Yuan , Y Wang , Y Wei , C Falke , C Cirelli , G Tononi , HK Manji , J Du (2009). Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology 56, 47–55.
LC Tishler , LB Gordon (1999). Ethical parameters of challenge studies inducing psychosis with ketamine. Ethics and Behavior 9, 211–217.
T Tsujimoto , H Shimazu , Y Isomura (2006). Direct recording of theta oscillations in primate prefrontal and anterior cingulate cortices. Journal of Neurophysiology 95, 2987–3000.
CA Zarate Jr., JB Singh , PJ Carlson , NE Brutsche , R Ameli , DA Luckenbaugh , DS Charney , HK Manji (2006). A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry 63, 856–864.